FI933821A - Foerfarande foer framstaellning av proteasinhibitorer - Google Patents

Foerfarande foer framstaellning av proteasinhibitorer Download PDF

Info

Publication number
FI933821A
FI933821A FI933821A FI933821A FI933821A FI 933821 A FI933821 A FI 933821A FI 933821 A FI933821 A FI 933821A FI 933821 A FI933821 A FI 933821A FI 933821 A FI933821 A FI 933821A
Authority
FI
Finland
Prior art keywords
proteasinhibitorer
foerfarande foer
foer framstaellning
production
novel
Prior art date
Application number
FI933821A
Other languages
English (en)
Other versions
FI933821A0 (fi
Inventor
Jutta Heim
Peter Fuerst
Thomas Hottiger
Jochen Kuhla
Gabriele Pohlig
Original Assignee
Ciba Geigy Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ucp Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of FI933821A0 publication Critical patent/FI933821A0/fi
Publication of FI933821A publication Critical patent/FI933821A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
FI933821A 1992-09-04 1993-09-01 Foerfarande foer framstaellning av proteasinhibitorer FI933821A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92810681 1992-09-04

Publications (2)

Publication Number Publication Date
FI933821A0 FI933821A0 (fi) 1993-09-01
FI933821A true FI933821A (fi) 1994-03-05

Family

ID=8211979

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933821A FI933821A (fi) 1992-09-04 1993-09-01 Foerfarande foer framstaellning av proteasinhibitorer

Country Status (20)

Country Link
US (1) US5726043A (fi)
EP (2) EP1031628A1 (fi)
JP (2) JP3949734B2 (fi)
KR (1) KR940007180A (fi)
AT (1) ATE196927T1 (fi)
AU (1) AU675071B2 (fi)
CA (1) CA2105425A1 (fi)
DE (1) DE69329540T2 (fi)
DK (1) DK0592358T3 (fi)
ES (1) ES2152943T3 (fi)
FI (1) FI933821A (fi)
GR (1) GR3035201T3 (fi)
HU (1) HU217094B (fi)
IL (1) IL106897A0 (fi)
MX (1) MX9305375A (fi)
NO (1) NO933153L (fi)
NZ (1) NZ248558A (fi)
PT (1) PT592358E (fi)
SG (1) SG49859A1 (fi)
ZA (1) ZA936507B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990010008A (ko) * 1997-07-14 1999-02-05 구광시 효모용 프로모터 및 이 프로모터를 포함하는 효모용발현 벡터
US6358705B1 (en) 1998-07-16 2002-03-19 Novo Nordisk A/S Method of making proteins in transformed yeast cells
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101512001A (zh) 2006-07-14 2009-08-19 诺维信股份有限公司 提高真菌细胞中基因表达的方法
CN102373216B (zh) * 2011-10-28 2013-06-05 元昊 一种含有医用水蛭素基因的重组真核汉逊酵母工程菌株的构建及重组水蛭素的生产工艺
EP3428282A1 (en) * 2017-07-11 2019-01-16 Alderys Ectoine-producing yeast

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940661A (en) * 1984-05-17 1990-07-10 Genentech, Inc. Metallothionein transcription control sequences and use thereof
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
AU614959B2 (en) * 1987-05-07 1991-09-19 Commonwealth Scientific And Industrial Research Organisation Expression system
PT88556B (pt) * 1987-09-28 1992-11-30 Smithkline Biolog Processo de integracao genomica estavel e de expressao de uma sequencia de cadificacao estranha, em leveduras
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche

Also Published As

Publication number Publication date
HU9302503D0 (en) 1993-11-29
EP1031628A1 (en) 2000-08-30
CA2105425A1 (en) 1994-03-05
JP3949734B2 (ja) 2007-07-25
EP0592358A2 (en) 1994-04-13
PT592358E (pt) 2001-03-30
DK0592358T3 (da) 2001-02-05
NZ248558A (en) 1995-04-27
DE69329540T2 (de) 2001-06-07
ZA936507B (en) 1994-03-23
IL106897A0 (en) 1993-12-28
FI933821A0 (fi) 1993-09-01
ES2152943T3 (es) 2001-02-16
US5726043A (en) 1998-03-10
SG49859A1 (en) 2002-03-19
JPH06165691A (ja) 1994-06-14
KR940007180A (ko) 1994-04-26
JP2004000288A (ja) 2004-01-08
NO933153D0 (no) 1993-09-03
HUT67307A (en) 1995-03-28
HU217094B (hu) 1999-11-29
NO933153L (no) 1994-03-07
ATE196927T1 (de) 2000-10-15
DE69329540D1 (de) 2000-11-16
AU675071B2 (en) 1997-01-23
EP0592358A3 (en) 1994-09-28
GR3035201T3 (en) 2001-04-30
MX9305375A (es) 1994-03-31
AU4499493A (en) 1994-03-10
EP0592358B1 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
DE68923123D1 (de) Herstellung von Proteinen.
DK172089A (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
SE9501544D0 (sv) Nytt förfarande
FI933821A0 (fi) Foerfarande foer framstaellning av proteasinhibitorer
EP0307472A4 (en) IMMUNOGENIC PRODUCT OBTAINED BY EXPRESSION FROM RECOMBINANT YEAST AND PROCESS FOR PURIFYING SUCH A PRODUCT.
EP0340170A3 (en) Process for the production of polypeptides
AU2085195A (en) Gene coding for igg-fc-binding protein
DK0619305T3 (da) Lactonforbindelse og fremgangsmåde til fremstilling deraf
FI881713A (fi) Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi
MX9702316A (es) Procesos para la preparacion del acido ciclopropancarboxilico y sus derivados.
EP0367598A3 (en) Novel process for the production of 4,6-dimethyl-7-hydroxynonan-3-one
EP0575776A3 (fi)
IL82503A0 (en) Process for the promination of biphenols
IE872279L (en) Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl¹-d-alanine.
IT1262957B (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.
IL83118A (en) N-acylated-n)- alkylcarbothioic acid hydrazides

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG